REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmaciya-Ekstempore OOO (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Farmaciya-Ekstempore OOO Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Farmaciya-Ekstempore OOO is a company in Russia, with a head office in Angarsk. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on November 10, 2004. There was a net sales revenue increase of 14% reported in Farmaciya-Ekstempore OOO’s latest financial highlights for 2023. Over the same period, its total assets decreased by 2.66%. The net profit margin of Farmaciya-Ekstempore OOO increased by 4.2% in 2023.

Headquarters
8, 14
Angarsk; Irkutsk Oblast; Postal Code: 665831

Contact Details: Purchase the Farmaciya-Ekstempore OOO report to view the information.

Website: http://kedrovit.ru

Basic Information
Outstanding Shares:
Purchase the Farmaciya-Ekstempore OOO report to view the information.
Registered Capital:
Purchase the Farmaciya-Ekstempore OOO report to view the information.
Incorporation Date:
November 10, 2004
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Farmaciya-Ekstempore OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
14%
Total operating revenue
14%
Operating profit (EBIT)
99.19%
Net Profit (Loss) for the Period
866.49%
Total assets
-2.66%
Total equity
20.75%
Operating Profit Margin (ROS)
4.78%
Net Profit Margin
4.2%
Return on Equity (ROE)
15.04%
Debt to Equity Ratio
-67.85%
Quick Ratio
-0.02%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?